Breakthrough Genomics
Provider of Advanced Genetic Tests and Tests for Early Cancer Detection
Provider of Advanced Genetic Tests and Tests for Early Cancer Detection
BREAKTHROUGH GENOMICS is a leader in the clinical interpretation of genomic data. The company has developed two proprietary AI-powered bioinformatic platforms and provides a range of tests for rare disease diagnosis and early cancer detection. BREAKTHROUGH GENOMICS also operates a CAP and CLIA-certified advanced clinical laboratory in Southern California where its team of scientists work to refine and develop new life-saving technologies.
There is no investment information
No recent news or press coverage available for Breakthrough Genomics.
股份有限公司-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.